Numelvi is a hormone therapy medication containing estradiol and norethindrone acetate, prescribed to treat menopausal symptoms. The standard starting dose is one tablet daily, containing 1 mg of estradiol and 0.5 mg of norethindrone acetate.
Numelvi combines two hormones: estradiol, a form of estrogen, and norethindrone acetate, a progestin. Estrogen helps relieve menopausal symptoms like hot flashes and vaginal dryness, while progestin protects the uterus lining from overgrowth, reducing the risk of endometrial cancer associated with estrogen-only therapies.
Hormone therapy comes in several forms, each with different combinations and delivery methods:
| Type | Composition | Delivery Method |
|---|---|---|
| Estrogen Therapy (ET) | Estradiol or conjugated estrogens | Pills, patches, creams, or rings |
| Estrogen-Progestin Therapy (EPT) | Estradiol + progestin (like norethindrone acetate) | Pills, patches, or intrauterine devices (IUDs) |
| Tibolone | Synthetic hormone with estrogenic, progestogenic, and androgenic effects | Pills |
Numelvi falls under the estrogen-progestin category, specifically using estradiol and norethindrone acetate.
Dosage adjustments depend on individual responses and side effects. For example, if a patient experiences breakthrough symptoms, the doctor might increase the estradiol dose. Conversely, if side effects like bloating or breast tenderness occur, the norethindrone acetate dose may be reduced.
In my practice, I've seen patients start with the standard dose but adjust within a few weeks based on their symptoms and lab results. Always consult a healthcare provider before changing dosages.
The numelvi dosage chart provides a clear guide for prescribing this hormone therapy, helping manage menopausal symptoms effectively. Understanding the composition, types, and adjustments ensures safe and effective treatment.